As expected, the overexpression of FENDRR in drug-resistant myeloid leukemia cells specifically decreased expression of MDR1, likely due to a decrease in HuR-bound MDR1 3′UTRs, and improved the responsiveness of those cells to adriamycin [49]. This evidence concerns the gene ABCB1 and myeloid leukemia.